InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Samuel George A. III. Director active across 1 company, notably Lineage Cell Therapeutics, Inc.. Cumulatively, 6 disclosures have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €9k. History available since 26 November 2024. The latest transaction was filed on 26 November 2024 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Samuel George A. III is a declarant linked to Lineage Cell Therapeutics, Inc., where he is General Counsel. The record shows 4 filings in total, and in the sampled recent filings, buys amount to EUR 8617 with no sells, between 2023-02-14 and 2025-02-12; the most frequent transaction nature indicated is option exercise.